These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 21449006)
1. Role of COMT, 5-HT(1A) , and SERT genetic polymorphisms on antidepressant response to Transcranial Magnetic Stimulation. Malaguti A; Rossini D; Lucca A; Magri L; Lorenzi C; Pirovano A; Colombo C; Smeraldi E; Zanardi R Depress Anxiety; 2011 Jul; 28(7):568-73. PubMed ID: 21449006 [TBL] [Abstract][Full Text] [Related]
2. Role of serotonergic gene polymorphisms on response to transcranial magnetic stimulation in depression. Zanardi R; Magri L; Rossini D; Malaguti A; Giordani S; Lorenzi C; Pirovano A; Smeraldi E; Lucca A Eur Neuropsychopharmacol; 2007 Oct; 17(10):651-7. PubMed ID: 17466494 [TBL] [Abstract][Full Text] [Related]
3. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study. Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207 [TBL] [Abstract][Full Text] [Related]
4. Interaction between serotonin transporter gene, catechol-O-methyltransferase gene and stressful life events in mood disorders. Mandelli L; Serretti A; Marino E; Pirovano A; Calati R; Colombo C Int J Neuropsychopharmacol; 2007 Aug; 10(4):437-47. PubMed ID: 16756688 [TBL] [Abstract][Full Text] [Related]
5. Patterns of response to repetitive transcranial magnetic stimulation (rTMS) in major depression: replication study in drug-free patients. Brakemeier EL; Wilbertz G; Rodax S; Danker-Hopfe H; Zinka B; Zwanzger P; Grossheinrich N; Várkuti B; Rupprecht R; Bajbouj M; Padberg F J Affect Disord; 2008 May; 108(1-2):59-70. PubMed ID: 17963846 [TBL] [Abstract][Full Text] [Related]
6. Acute antidepressant response to sleep deprivation combined with light therapy is influenced by the catechol-O-methyltransferase Val(108/158)Met polymorphism. Benedetti F; Barbini B; Bernasconi A; Fulgosi MC; Dallaspezia S; Gavinelli C; Locatelli C; Lorenzi C; Pirovano A; Radaelli D; Smeraldi E; Colombo C J Affect Disord; 2010 Feb; 121(1-2):68-72. PubMed ID: 19520435 [TBL] [Abstract][Full Text] [Related]
8. Neural and genetic correlates of antidepressant response to sleep deprivation: a functional magnetic resonance imaging study of moral valence decision in bipolar depression. Benedetti F; Bernasconi A; Blasi V; Cadioli M; Colombo C; Falini A; Lorenzi C; Radaelli D; Scotti G; Smeraldi E Arch Gen Psychiatry; 2007 Feb; 64(2):179-87. PubMed ID: 17283285 [TBL] [Abstract][Full Text] [Related]
9. Serotonin transporter polymorphism in Croatian patients with major depressive disorder. Bozina N; Mihaljević-Peles A; Sagud M; Jakovljević M; Sertić J Psychiatr Danub; 2006 Jun; 18(1-2):83-9. PubMed ID: 16804504 [TBL] [Abstract][Full Text] [Related]
10. Serotonin-transporter-linked promoter region polymorphism and serotonin transporter binding in drug-naïve patients with major depression. Joensuu M; Lehto SM; Tolmunen T; Saarinen PI; Valkonen-Korhonen M; Vanninen R; Ahola P; Tiihonen J; Kuikka J; Pesonen U; Lehtonen J Psychiatry Clin Neurosci; 2010 Aug; 64(4):387-93. PubMed ID: 20653909 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center. Connolly KR; Helmer A; Cristancho MA; Cristancho P; O'Reardon JP J Clin Psychiatry; 2012 Apr; 73(4):e567-73. PubMed ID: 22579164 [TBL] [Abstract][Full Text] [Related]
12. Catechol-O-methyltransferase (COMT) polymorphisms predict treatment response in electroconvulsive therapy. Anttila S; Huuhka K; Huuhka M; Illi A; Rontu R; Leinonen E; Lehtimäki T Pharmacogenomics J; 2008 Apr; 8(2):113-6. PubMed ID: 17700596 [TBL] [Abstract][Full Text] [Related]
13. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder. Lin E; Chen PS; Chang HH; Gean PW; Tsai HC; Yang YK; Lu RB Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1167-72. PubMed ID: 19560507 [TBL] [Abstract][Full Text] [Related]
14. Association between catechol-O-methyltransferase Val(108/158)Met polymorphism and psychotic features of bipolar disorder. Benedetti F; Dallaspezia S; Colombo C; Lorenzi C; Pirovano A; Smeraldi E J Affect Disord; 2010 Sep; 125(1-3):341-4. PubMed ID: 20122740 [TBL] [Abstract][Full Text] [Related]
17. Dopamine 2 receptor C957T and catechol-o-methyltransferase Val158Met polymorphisms are associated with treatment response in electroconvulsive therapy. Huuhka K; Anttila S; Huuhka M; Hietala J; Huhtala H; Mononen N; Lehtimäki T; Leinonen E Neurosci Lett; 2008 Dec; 448(1):79-83. PubMed ID: 18929622 [TBL] [Abstract][Full Text] [Related]
18. Catechol-o-methyltransferase (COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression. Tunbridge E; Burnet PW; Sodhi MS; Harrison PJ Synapse; 2004 Feb; 51(2):112-8. PubMed ID: 14618678 [TBL] [Abstract][Full Text] [Related]
19. Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression. Maron E; Tammiste A; Kallassalu K; Eller T; Vasar V; Nutt DJ; Metspalu A Eur Neuropsychopharmacol; 2009 Jun; 19(6):451-6. PubMed ID: 19272758 [TBL] [Abstract][Full Text] [Related]
20. The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression. Szegedi A; Rujescu D; Tadic A; Müller MJ; Kohnen R; Stassen HH; Dahmen N Pharmacogenomics J; 2005; 5(1):49-53. PubMed ID: 15520843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]